Loss on 18q included the well known 18q21.1 area which is known to harbour the tumour suppressor genes SMAD2 [24] and SMAD4 [25], which function in the TGFβ-pathway e.g. to mediate the growth-inhibitory effects of this cytokine. This evidence concerns the gene SMAD4 and neoplasm.